1. Nonoptimal Vaginal Microbiota After Azithromycin Treatment for Chlamydia trachomatis Infection.
- Author
-
Tamarelle J, Ma B, Gajer P, Humphrys MS, Terplan M, Mark KS, Thiébaut ACM, Forney LJ, Brotman RM, Delarocque-Astagneau E, Bavoil PM, and Ravel J
- Subjects
- Adolescent, Adult, Anti-Bacterial Agents administration & dosage, Anti-Bacterial Agents adverse effects, Anti-Bacterial Agents pharmacology, Azithromycin administration & dosage, Azithromycin adverse effects, Azithromycin pharmacology, Chlamydia Infections microbiology, Cross-Sectional Studies, Female, Follow-Up Studies, Gardnerella vaginalis drug effects, Gardnerella vaginalis genetics, Humans, Lactobacillus drug effects, Lactobacillus genetics, Microbiota genetics, Prospective Studies, RNA, Ribosomal, 16S, Treatment Outcome, Vaginosis, Bacterial microbiology, Young Adult, Anti-Bacterial Agents therapeutic use, Azithromycin therapeutic use, Chlamydia Infections drug therapy, Chlamydia trachomatis genetics, Microbiota drug effects, Vagina microbiology, Vaginosis, Bacterial drug therapy
- Abstract
We characterized the composition and structure of the vaginal microbiota in a cohort of 149 women with genital Chlamydia trachomatis infection at baseline who were followed quarterly for 9 months after antibiotic treatment. At time of diagnosis, the vaginal microbiota was dominated by Lactobacillus iners or a diverse array of bacterial vaginosis-associated bacteria including Gardnerella vaginalis. Interestingly, L. iners-dominated communities were most common after azithromycin treatment (1 g monodose), consistent with the observed relative resistance of L. iners to azithromycin. Lactobacillus iners-dominated communities have been associated with increased risk of C. trachomatis infection, suggesting that the impact of antibiotic treatment on the vaginal microbiota could favor reinfections. These results provide support for the dual need to account for the potential perturbing effect(s) of antibiotic treatment on the vaginal microbiota, and to develop strategies to protect and restore optimal vaginal microbiota., (© The Author(s) 2019. Published by Oxford University Press for the Infectious Diseases Society of America.)
- Published
- 2020
- Full Text
- View/download PDF